One solution, exponential insight

Watch the video

Using biomodal duet multiomics software

Finally see it all

Uncover the biomarkers you’re searching for with a single workflow solution. biomodal’s multiomic analysis provides both genetic and epigenetic data simultaneously with groundbreaking clarity, precision and speed.

One sample, one workflow, one solution

duet multiomics solution +modC workflow

This approach provides the most efficient way to obtain genetic and methylation information simultaneously.

Conventional methods: 2 samples, 2 workflows, 3+ data analyses

These approaches require splitting the sample and running parallel workflows, with multiple data analyses and significant information loss.

A single comprehensive workflow to uncover the DNA modifications that matter

Using biomodal duet multiomics software

Applications for multiomics discovery

Scientist working

Cancer research

Multiomics analysis offers a deeper understanding of the drivers of cancer. Our technology allows you to bring multiomic analysis to your research using your existing DNA sequencing infrastructure.

Ageing

Ageing

Probe and determine the markers of biological age to better understand age-related diseases including Alzheimer’s disease, osteoporosis, type II diabetes and chronic heart disease.

Population genetics

Population genetics

Investigate genome-wide methylation patterns across populations with a single solution and integrated data.

Non-invasive prenatal testing

Non-invasive prenatal testing

Combining genetic and epigenetic DNA sequencing has the potential to reduce the time taken to detect pregnancy complications and significant genetic and epigenetic variations in a foetus.

Neurodegenerative disease

Neurodegenerative disease

Reveal the role of DNA methylation in the most common neurodegenerative diseases, and identify potential targets for promising therapeutics.

Precision medicine

Precision medicine

Use multiomics analysis to identify targets for promising therapeutics tailored to the genetics and epigenetics of the individual.

Explore our science

Cambridge Epigenetix is now biomodal